Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220822164> ?p ?o ?g. }
- W4220822164 endingPage "e12994" @default.
- W4220822164 startingPage "e12994" @default.
- W4220822164 abstract "Septic cardiomyopathy (SC) is a common complication of sepsis that leads to an increase in mortality. The pathogenesis of septic cardiomyopathy is unclear, and there is currently no effective treatment. EGCG (epigallocatechin gallate) is a polyphenol that has anti-inflammatory, antiapoptotic, and antioxidative stress effects. However, the role of EGCG in septic cardiomyopathy is unknown.Network pharmacology was used to predict the potential targets and molecular mechanisms of EGCG in the treatment of septic cardiomyopathy, including the construction and analysis of protein-protein interaction (PPI) network, gene ontology (GO), and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis and molecular docking. The mouse model of septic cardiomyopathy was established after intraperitoneal injection of LPS (lipopolysaccharide). The myocardial protective effect of EGCG on septic mice is observed by cardiac ultrasound and HE staining. RT-PCR is used to verify the expression level of the EGCG target in the septic cardiomyopathy mouse model.A total of 128 anti-SC potential targets of EGCGareselected for analysis. The GO enrichment analysis and KEGG pathway analysis results indicated that the anti-SC targets of EGCG mainly participate in inflammatory and apoptosis processes. Molecular docking results suggest that EGCG has a high affinity for the crystal structure of six targets (IL-6 (interleukin-6), TNF (tumor necrosis factor), Caspase3, MAPK3 (Mitogen-activated protein kinase 3), AKT1, and VEGFA (vascular endothelial growth factor)), and the experimental verification result showed levated expression of these 6 hub targets in the LPS group, but there is an obvious decrease in expression in the LPS + EGCG group. The functional and morphological changes found by echocardiography and HE staining show that EGCG can effectively improve the cardiac function that is reduced by LPS.Our results reveal that EGCG may be a potentially effective drug to improve septic cardiomyopathy. The potential mechanism by which EGCG improves myocardial injury in septic cardiomyopathy is through anti-inflammatory and anti-apoptotic effects. The anti-inflammatory and anti-apoptotic effects of EGCG occur not only through direct binding to six target proteins (IL-6,TNF-α, Caspase3, MAPK3, AKT1, and VEGFA) but also by reducing their expression." @default.
- W4220822164 created "2022-04-03" @default.
- W4220822164 creator A5002338347 @default.
- W4220822164 creator A5007375337 @default.
- W4220822164 creator A5010954066 @default.
- W4220822164 creator A5015303913 @default.
- W4220822164 creator A5017808406 @default.
- W4220822164 creator A5033563196 @default.
- W4220822164 creator A5048592635 @default.
- W4220822164 creator A5058899630 @default.
- W4220822164 creator A5063472996 @default.
- W4220822164 creator A5073070877 @default.
- W4220822164 date "2022-03-09" @default.
- W4220822164 modified "2023-10-16" @default.
- W4220822164 title "Analysis of the role and mechanism of EGCG in septic cardiomyopathy based on network pharmacology" @default.
- W4220822164 cites W1906327883 @default.
- W4220822164 cites W1974950902 @default.
- W4220822164 cites W2081236313 @default.
- W4220822164 cites W2103017472 @default.
- W4220822164 cites W2103912979 @default.
- W4220822164 cites W2128805286 @default.
- W4220822164 cites W2132399579 @default.
- W4220822164 cites W2152575820 @default.
- W4220822164 cites W2557012249 @default.
- W4220822164 cites W2559588208 @default.
- W4220822164 cites W2617904586 @default.
- W4220822164 cites W2741151004 @default.
- W4220822164 cites W2752514371 @default.
- W4220822164 cites W2765327913 @default.
- W4220822164 cites W2799712382 @default.
- W4220822164 cites W2889367571 @default.
- W4220822164 cites W2893942412 @default.
- W4220822164 cites W2898106124 @default.
- W4220822164 cites W2900692563 @default.
- W4220822164 cites W2921971526 @default.
- W4220822164 cites W2950937623 @default.
- W4220822164 cites W2976466759 @default.
- W4220822164 cites W2982019182 @default.
- W4220822164 cites W2983752405 @default.
- W4220822164 cites W2994813412 @default.
- W4220822164 cites W2997565160 @default.
- W4220822164 cites W3021834206 @default.
- W4220822164 cites W3025667250 @default.
- W4220822164 cites W3034117548 @default.
- W4220822164 cites W3035434694 @default.
- W4220822164 cites W3092080734 @default.
- W4220822164 cites W3092890104 @default.
- W4220822164 cites W3107437102 @default.
- W4220822164 cites W3112690917 @default.
- W4220822164 cites W3120650872 @default.
- W4220822164 cites W3121798646 @default.
- W4220822164 cites W3122387751 @default.
- W4220822164 cites W3134411132 @default.
- W4220822164 cites W3136205028 @default.
- W4220822164 cites W3141205210 @default.
- W4220822164 cites W3154968664 @default.
- W4220822164 cites W3157600289 @default.
- W4220822164 cites W3158437867 @default.
- W4220822164 cites W3158975695 @default.
- W4220822164 cites W3159680461 @default.
- W4220822164 cites W3161189792 @default.
- W4220822164 cites W3161900646 @default.
- W4220822164 cites W3164962290 @default.
- W4220822164 cites W3165243661 @default.
- W4220822164 cites W4211227031 @default.
- W4220822164 doi "https://doi.org/10.7717/peerj.12994" @default.
- W4220822164 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35287352" @default.
- W4220822164 hasPublicationYear "2022" @default.
- W4220822164 type Work @default.
- W4220822164 citedByCount "1" @default.
- W4220822164 countsByYear W42208221642023 @default.
- W4220822164 crossrefType "journal-article" @default.
- W4220822164 hasAuthorship W4220822164A5002338347 @default.
- W4220822164 hasAuthorship W4220822164A5007375337 @default.
- W4220822164 hasAuthorship W4220822164A5010954066 @default.
- W4220822164 hasAuthorship W4220822164A5015303913 @default.
- W4220822164 hasAuthorship W4220822164A5017808406 @default.
- W4220822164 hasAuthorship W4220822164A5033563196 @default.
- W4220822164 hasAuthorship W4220822164A5048592635 @default.
- W4220822164 hasAuthorship W4220822164A5058899630 @default.
- W4220822164 hasAuthorship W4220822164A5063472996 @default.
- W4220822164 hasAuthorship W4220822164A5073070877 @default.
- W4220822164 hasBestOaLocation W42208221641 @default.
- W4220822164 hasConcept C104317684 @default.
- W4220822164 hasConcept C126322002 @default.
- W4220822164 hasConcept C150194340 @default.
- W4220822164 hasConcept C152724338 @default.
- W4220822164 hasConcept C162317418 @default.
- W4220822164 hasConcept C17991360 @default.
- W4220822164 hasConcept C203014093 @default.
- W4220822164 hasConcept C2778198053 @default.
- W4220822164 hasConcept C2778384902 @default.
- W4220822164 hasConcept C2778797674 @default.
- W4220822164 hasConcept C502942594 @default.
- W4220822164 hasConcept C55493867 @default.
- W4220822164 hasConcept C71924100 @default.
- W4220822164 hasConcept C86803240 @default.
- W4220822164 hasConcept C98274493 @default.